Bioadvise ApS: Financial statements 2021
CVR: 39920034
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Bioadvise ApS (CVR 39920034) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 122,164 and a net result of DKK 53,189 compared with DKK 90,794 the year before. That is a decrease of 72.7% compared with the year before. Equity in the 2021 report amounted to DKK 380,721. The solvency ratio was 83.1%.
- Gross Profit
- DKK 122,164
- Profit/Loss
- DKK 53,189
- Equity
- DKK 380,721
- Total Assets
- DKK 458,155
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 122 t. | 53 t. | 381 t. | 0 |
| 2020 | - | 448 t. | 91 t. | 289 t. | 1 |
| 2019 | - | 377 t. | 77 t. | 198 t. | 1 |
Official annual report
Find more companies like Bioadvise ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
On September 14, 2021, the company changed its name from Bioadvise IVS to Bioadvise ApS.
Bioadvise ApS has published its annual report for 2020. Gross profit came to DKK 447,895, and the net result was DKK 90,794.
About Bioadvise ApS
Bioadvise ApS was a Danish company of the type Anpartsselskab based in Kongens Lyngby, founded in 2018. The company has been dissolved on 21 September 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Bioadvise IVS. The company has 1 employee (2020). In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -210,600 the year before. Equity in the 2025 report amounted to DKK -34,634.